223 related articles for article (PubMed ID: 22267545)
1. Cadherin-11, a marker of the mesenchymal phenotype, regulates glioblastoma cell migration and survival in vivo.
Kaur H; Phillips-Mason PJ; Burden-Gulley SM; Kerstetter-Fogle AE; Basilion JP; Sloan AE; Brady-Kalnay SM
Mol Cancer Res; 2012 Mar; 10(3):293-304. PubMed ID: 22267545
[TBL] [Abstract][Full Text] [Related]
2. Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma.
Martins EP; Gonçalves CS; Pojo M; Carvalho R; Ribeiro AS; Miranda-Gonçalves V; Taipa R; Pardal F; Pinto AA; Custódia C; Faria CC; Baltazar F; Sousa N; Paredes J; Costa BM
Mol Oncol; 2022 Jul; 16(14):2611-2631. PubMed ID: 34919784
[TBL] [Abstract][Full Text] [Related]
3. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
4. N-cadherin upregulation mediates adaptive radioresistance in glioblastoma.
Osuka S; Zhu D; Zhang Z; Li C; Stackhouse CT; Sampetrean O; Olson JJ; Gillespie GY; Saya H; Willey CD; Van Meir EG
J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33720050
[TBL] [Abstract][Full Text] [Related]
5. Misregulated E-cadherin expression associated with an aggressive brain tumor phenotype.
Lewis-Tuffin LJ; Rodriguez F; Giannini C; Scheithauer B; Necela BM; Sarkaria JN; Anastasiadis PZ
PLoS One; 2010 Oct; 5(10):e13665. PubMed ID: 21060868
[TBL] [Abstract][Full Text] [Related]
6. B7H3 regulates differentiation and serves as a potential biomarker and theranostic target for human glioblastoma.
Zhang J; Wang J; Marzese DM; Wang X; Yang Z; Li C; Zhang H; Zhang J; Chen CC; Kelly DF; Hua W; Hoon DSB; Mao Y
Lab Invest; 2019 Jul; 99(8):1117-1129. PubMed ID: 30914782
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9.
Liu N; Zhang L; Wang Z; Cheng Y; Zhang P; Wang X; Wen W; Yang H; Liu H; Jin W; Zhang Y; Tu Y
Oncotarget; 2017 Mar; 8(12):19244-19254. PubMed ID: 27911279
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor 13 regulates glioma cell invasion and is important for bevacizumab-induced glioma invasion.
Otani Y; Ichikawa T; Kurozumi K; Inoue S; Ishida J; Oka T; Shimizu T; Tomita Y; Hattori Y; Uneda A; Matsumoto Y; Michiue H; Date I
Oncogene; 2018 Feb; 37(6):777-786. PubMed ID: 29059154
[TBL] [Abstract][Full Text] [Related]
9. NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma.
Guo Q; Han N; Shi L; Yang L; Zhang X; Zhou Y; Yu S; Zhang M
Oncol Rep; 2019 Sep; 42(3):963-972. PubMed ID: 31322259
[TBL] [Abstract][Full Text] [Related]
10. FOXO1 associated with sensitivity to chemotherapy drugs and glial-mesenchymal transition in glioma.
Chen C; Han G; Li Y; Yue Z; Wang L; Liu J
J Cell Biochem; 2019 Jan; 120(1):882-893. PubMed ID: 30216501
[TBL] [Abstract][Full Text] [Related]
11. Targeting TWIST1 through loss of function inhibits tumorigenicity of human glioblastoma.
Mikheev AM; Mikheeva SA; Severs LJ; Funk CC; Huang L; McFaline-Figueroa JL; Schwensen J; Trapnell C; Price ND; Wong S; Rostomily RC
Mol Oncol; 2018 Jun; 12(7):1188-1202. PubMed ID: 29754406
[TBL] [Abstract][Full Text] [Related]
12. AJAP1 expression modulates glioma cell motility and correlates with tumor growth and survival.
Di C; Mladkova N; Lin J; Fee B; Rivas M; Chunsheng K; Bigner D; Adamson DC
Int J Oncol; 2018 Jan; 52(1):47-54. PubMed ID: 29115565
[TBL] [Abstract][Full Text] [Related]
13. The PDK1/c‑Jun pathway activated by TGF‑β induces EMT and promotes proliferation and invasion in human glioblastoma.
Luo D; Xu X; Li J; Chen C; Chen W; Wang F; Xie Y; Li F
Int J Oncol; 2018 Nov; 53(5):2067-2080. PubMed ID: 30106127
[TBL] [Abstract][Full Text] [Related]
14. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.
Di K; Linskey ME; Bota DA
Oncogene; 2013 Oct; 32(42):5038-47. PubMed ID: 23178488
[TBL] [Abstract][Full Text] [Related]
15. RND3 promotes Snail 1 protein degradation and inhibits glioblastoma cell migration and invasion.
Liu B; Dong H; Lin X; Yang X; Yue X; Yang J; Li Y; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Mao S; Chen Q; Chang J
Oncotarget; 2016 Dec; 7(50):82411-82423. PubMed ID: 27705942
[TBL] [Abstract][Full Text] [Related]
16. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
[TBL] [Abstract][Full Text] [Related]
17. CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study.
Yadav VN; Zamler D; Baker GJ; Kadiyala P; Erdreich-Epstein A; DeCarvalho AC; Mikkelsen T; Castro MG; Lowenstein PR
Oncotarget; 2016 Dec; 7(50):83701-83719. PubMed ID: 27863376
[TBL] [Abstract][Full Text] [Related]
18. BMP4 inhibits glioblastoma invasion by promoting E-cadherin and claudin expression.
Zhao X; Sun Q; Dou C; Chen Q; Liu B
Front Biosci (Landmark Ed); 2019 Mar; 24(6):1060-1070. PubMed ID: 30844730
[TBL] [Abstract][Full Text] [Related]
19. SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties.
Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Aboody KS
Stem Cells Dev; 2017 Sep; 26(17):1236-1246. PubMed ID: 28610554
[TBL] [Abstract][Full Text] [Related]
20. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
